Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients.
about
N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosisShould we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.Pharmacogenetics in drug regulation: promise, potential and pitfalls.NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast regionPharmGED: Pharmacogenetic Effect Database.A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.Role of pharmacogenomics in the treatment of tuberculosis: a reviewCan pharmacogenetics help rescue drugs withdrawn from the market?Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB?A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis.Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype.Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
P2860
Q33768531-02379BD8-9506-4D4C-BC90-743F90F69DAAQ33770163-CA07134D-2CB4-4E19-A004-BD51157AC264Q34606196-246D5E3E-877F-49B5-B631-8B6819144E72Q35038052-80291B5D-BCA1-4CC5-AC96-5271760CE309Q35149733-2C42D603-9CC3-48A2-B609-3232608567EBQ35567962-AFEC0A1F-289A-400C-98C7-3C980040765DQ35617587-83EBACCE-74D3-4AE8-9FC4-2425FC3D7185Q35774965-B73F9F76-B57C-4941-A48F-B664047E9021Q36441540-6E9807D6-AE88-4ECA-B9C1-6DF773693381Q36596713-F4ABC93A-B298-471C-B79D-01DE03910DF8Q40035394-383527AB-71F4-49DE-BDF4-04AFF54530B3Q40592548-58B80E54-7D32-4BCC-B0E1-CCDFDCD9E09AQ41679231-2351071D-413B-4A7D-AA26-8EAAD2799D11Q43248041-5DC89C49-DEC7-4939-B64F-8369B2CCFB7DQ43611407-BCABA27B-F372-4E99-90FF-62B861BB9BA7Q46058560-94E02764-B93A-4291-9F3D-DC1A8712020DQ51950592-84AABDF6-956C-467C-A52C-53C04A468A5AQ53765768-D611FBD1-BEA3-4E93-A396-8AFC8EF54B46
P2860
Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Genotyping of the N-acetyltran ...... soniazid in Japanese patients.
@en
type
label
Genotyping of the N-acetyltran ...... soniazid in Japanese patients.
@en
prefLabel
Genotyping of the N-acetyltran ...... soniazid in Japanese patients.
@en
P2093
P356
P1476
Genotyping of the N-acetyltran ...... soniazid in Japanese patients.
@en
P2093
Junichi Goto
Kaori Narahara
Masahiro Hiratsuka
Masaki Matsuura
Michinao Mizugaki
Naomi Endo
Samar Ismail Hamdy
Tomoko Inoue
Yoh Takekuma
Yukinaga Kishikawa
P304
P356
10.2133/DMPK.17.357
P577
2002-01-01T00:00:00Z